β-紫罗兰酮抗癌活性研究进展

doi:10.11904/j.issn.1002-3070.2021.03.014

实用肿瘤学杂志 ›› 2021, Vol. 35 ›› Issue (3): 268-272.doi: 10.11904/j.issn.1002-3070.2021.03.014

β-紫罗兰酮抗癌活性研究进展

石远洋^1,2 综述, 刘家仁^1,2 审校

1.哈尔滨医科大学附属第四医院检验科(哈尔滨 150001);
2.黑龙江龙卫精准医学检验中心

收稿日期:2020-08-24 修回日期:2020-10-09 出版日期:2021-06-28 发布日期:2021-06-22
通讯作者: 刘家仁,E-mail:Jiarenliu@hrbmu.edu.cn
作者简介:石远洋,女,(1998-),硕士研究生,从事植物化学物在肿瘤方面的研究。
基金资助:
哈尔滨市科技创新人才研究专项基金(编号:2017RALXJ005)

Research progress in anticancer activity of β-ionone

SHI Yuanyang^1,2, LIU Jiaren^1,2

1. Department of Clinical Laboratory,The Forth Affiliated Hospital of Harbin Medical University,Harbin 150001,China;
2. Heilongjiang Longwei Precision Medical Laboratory Center

Received:2020-08-24 Revised:2020-10-09 Online:2021-06-28 Published:2021-06-22

摘要/Abstract

摘要： β-紫罗兰酮(β-Ionone,BI)是一类环化异戊二烯,广泛分布于水果和蔬菜中。BI具有多种生物活性,其抗癌活性是当前研究的热点,并可成为一种潜在的癌症化学预防剂。为更好地理解其抑制肿瘤方面的作用及其机制,本文对BI近年来研究进展进行简要地综述。

关键词: β-紫罗兰酮, 抑癌作用, 机制

Abstract: Beta-ionone(BI)is a type of cyclized isoprene,widely distributed in fruits and vegetables.BI has a variety of biological activities,and its anti-cancer activity is a hot spot in current research.It can become a potential cancer chemopreventive agent.In order to better understand its effect on anti-tumor activity and its possible mechanism,this article briefly reviews the research progress in the effects of β-ionone on the activity of anti-tumor in recent years.

Key words: β-Ionone, Antitumor activity, Mechanism

中图分类号:

石远洋, 刘家仁. β-紫罗兰酮抗癌活性研究进展[J]. 实用肿瘤学杂志, 2021, 35(3): 268-272.

SHI Yuanyang, LIU Jiaren. Research progress in anticancer activity of β-ionone[J]. Journal of Practical Oncology, 2021, 35(3): 268-272.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/10.11904/j.issn.1002-3070.2021.03.014

http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/Y2021/V35/I3/268

参考文献

1 果思伽,刘家仁.植物化学物在癌症化学预防中的作用[J].实用肿瘤学杂志,2020,34(5):460-465.
2 Zhang H,Liu J,Li G,et al.Fresh red raspberry phytochemicals suppress the growth of hepatocellular carcinoma cells by PTEN/AKT pathway[J].Int J Biochem Cell Biol,2018,104:55-65.
3 常晓霞,宋冰冰,刘家仁.植物化学物增加肿瘤细胞对化疗药物敏感性的研究进展[J].实用肿瘤学杂志,2019,33(1):67-71.
4 Liu Q,Dong HW,Sun WG,et al.Apoptosis initiation of beta-ionone in SGC-7901 gastric carcinoma cancer cells via a PI3K-AKT pathway[J].Arch Toxicol,2013,87(3):481-490.
5 Liu JR,Chen BQ,Yang BF,et al.Apoptosis of human gastric adenocarcinoma cells induced by beta-ionone[J].World J Gastroenterol,2004,10(3):348-351.
6 Liu JR,Yang BF,Chen BQ,et al.Inhibition of beta-ionone on SGC-7901 cell proliferation and upregulation of metalloproteinases-1 and-2 expression[J].World J Gastroenterol,2004,10(2):167-171.
7 刘家仁,杨艳梅,董宏伟,等.β-紫罗兰酮对人乳腺癌细胞(Er-)MAPK途径的影响[J].卫生研究,2005,34(6):706-709.
8 Liu JR,Sun XR,Dong HW,et al.beta-Ionone suppresses mammary carcinogenesis,proliferative activity and induces apoptosis in the mammary gland of the Sprague-Dawley rat[J].Int J Cancer,2008,122(12):2689-2698.
9 孙向荣,刘家仁,陈炳卿.b-紫罗兰酮的生物活性研究进展[J].毒理学杂志,2008,22(6):477-480.
10 Sharma V,Singh G,Kaur H,et al.Synthesis of beta-ionone derived chalcones as potent antimicrobial agents[J].Bioorg Med Chem Lett,2012,22(20):6343-6346.
11 De Moura Espindola R,Mazzantini RP,Ong TP,et al.Geranylgeraniol and beta-ionone inhibit hepatic preneoplastic lesions,cell proliferation,total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis,but only the former inhibits NF-kappaB activation[J].Carcinogenesis,2005,26(6):1091-1099.
12 刘家仁,李百祥,马若波,等.β-紫罗兰酮对人乳腺癌细胞抑制作用[J].卫生研究,2004,33(2):151-153.
13 董宏伟,王琪,金德利,等.β-紫罗兰酮诱导人乳腺癌细胞(ER+)凋亡作用[J].中国公共卫生,2015,31(2):193-195.
14 Dong HW,Zhang S,Sun WG,et al.beta-Ionone arrests cell cycle of gastric carcinoma cancer cells by a MAPK pathway[J].Arch Toxicol,2013,87(10):1797-808.
15 Kim MO,Moon DO,Kang CH,et al.beta-Ionone enhances TRAIL-induced apoptosis in hepatocellular carcinoma cells through Sp1-dependent upregulation of DR5 and downregulation of NF-kappaB activity[J].Mol Cancer Ther,2010,9(4):833-843.
16 Huang CS,Lyu SC,Hu ML.Synergistic effects of the combination of beta-ionone and sorafenib on metastasis of human hepatoma SK-Hep-1 cells[J].Invest New Drugs,2012,30(4):1449-1459.
17 Jones S,Fernandes NV,Yeganehjoo H,et al.beta-ionone induces cell cycle arrest and apoptosis in human prostate tumor cells[J].Nutr Cancer,2013,65(4):600-610.
18 Xie H,Liu T,Chen J,et al.Activation of PSGR with beta-ionone suppresses prostate cancer progression by blocking androgen receptor nuclear translocation[J].Cancer Lett,2019,453:193-205.
19 He L,Mo H,Hadisusilo S,et al.Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo[J].J Nutr,1997,127(5):668-674.
20 Mo H,Elson CE.Apoptosis and cell-cycle arrest in human and murine tumor cells are initiated by isoprenoids[J].J Nutr,1999,129(4):804-813.
21 Zhu J,Zhang L,Jin X,et al.beta-Ionone-induced apoptosis in human osteosarcoma(U2os)cells occurs via a p53-dependent signaling pathway[J].Mol Biol Rep,2010,37(6):2653-2663.
22 Cardozo MT,De Conti A,Ong TP,et al.Chemopreventive effects of beta-ionone and geraniol during rat hepatocarcinogenesis promotion:distinct actions on cell proliferation,apoptosis,HMGCoA reductase,and RhoA[J].J Nutr Biochem,2011,22(2):130-135.
23 Abd-Elbaset M,Mansour AM,Ahmed OM,et al.The potential chemotherapeutic effect of beta-ionone and/or sorafenib against hepatocellular carcinoma via its antioxidant effect,PPAR-gamma,FOXO-1,Ki-67,Bax,and Bcl-2 signaling pathways[J].Naunyn Schmiedebergs Arch Pharmacol,2020,393(9):1611-1624.
24 Asokkumar S,Naveenkumar C,Raghunandhakumar S,et al.Antiproliferative and antioxidant potential of beta-ionone against benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice[J].Mol Cell Biochem,2012,363(1-2):335-345.
25 Duncan RE,Lau D,El-Sohemy A,et al.Geraniol and beta-ionone inhibit proliferation,cell cycle progression,and cyclin-dependent kinase 2 activity in MCF-7 breast cancer cells independent of effects on HMG-CoA reductase activity[J].Biochem Pharmacol,2004,68(9):1739-1747.
26 Dong HW,Wang K,Chang XX,et al.Beta-ionone-inhibited proliferation of breast cancer cells by inhibited COX-2 activity[J].Arch Toxicol,2019,93(10):2993-3003.
27 Liu JR,Dong HW,Sun XR,et al.Effects of beta-ionone on mammary carcinogenesis and antioxidant status in rats treated with DMBA[J].Nutr Cancer,2010,62(1):58-65.
28 Hashemi Goradel N,Najafi M,Salehi E,et al.Cyclooxygenase-2 in cancer:a review[J].J Cell Physiol,2019,234(5):5683-5699.
29 刘家仁,陈炳卿,杨艳梅,等.β-紫罗兰酮抑制SGC-7901 细胞潜在的转移作用[J].卫生研究,2005,34(4):435-438.
30 Shaw RJ,Cantley LC.Ras,PI(3)K and mTOR signalling controls tumour cell growth[J].Nature,2006,441(7092):424-430.
31 Kholodenko BN,Birtwistle MR.Four-dimensional dynamics of MAPK information processing systems[J].Wiley Interdiscip Rev Syst Biol Med,2009,1(1):28-44.
32 Wang J,Weng J,Cai Y,et al.The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase[J].Prostate,2006,66(8):847-857.
33 Scolastici C,De Conti A,Cardozo MT,et al.beta-ionone inhibits persistent preneoplastic lesions during the early promotion phase of rat hepatocarcinogenesis:TGF-alpha,NF-kappaB,and p53 as cellular targets[J].Nutr Cancer,2014,66(2):234-241.
34 Ansari M,Emami S.beta-Ionone and its analogs as promising anticancer agents[J].Eur J Med Chem,2016,123:141-154.

[1]	尹琦, 胡彦建, 崔普泽, 胡彦华. Notch信号通路调控肿瘤细胞凋亡机制研究进展[J]. 实用肿瘤学杂志, 2021, 35(2): 165-169.
[2]	杨思琦,宋启斌,李清清(综述),姚颐(审校). 靶向抑制FGFRs信号在治疗恶性肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2021, 35(1): 73-77.
[3]	党瑶,皇甫辉,秦艺骁,车琴,郝晓龙(综述),王斌全(审校). 头颈部鳞状细胞癌转移机制及其影响因素研究进展[J]. 实用肿瘤学杂志, 2021, 35(1): 78-82.
[4]	韩静, 蒲艳, 柳惠斌. SKA1对肾细胞癌细胞增殖凋亡的影响及其分子机制研究[J]. 实用肿瘤学杂志, 2020, 34(5): 404-411.
[5]	张孟哲, 康向东. Krüpple样转录因子4与结肠癌发生发展关系的研究进展[J]. 实用肿瘤学杂志, 2020, 34(5): 456-459.
[6]	赵颖欣, 秦玲. 二甲双胍与多发性骨髓瘤的研究进展[J]. 实用肿瘤学杂志, 2020, 34(5): 476-479.
[7]	陈澜涛, 颜巍, 刘静蕾, 姚磊. 防己诺林碱对肺癌H1299和A549细胞的作用及其分子机制研究[J]. 实用肿瘤学杂志, 2020, 34(2): 126-132.
[8]	刘光霞, 赵连春, 陈芳, 贾乾, 高伟, 侯瞻, 卢亚敏. ZCCHC12对甲状腺细胞恶性转化的影响与作用机制[J]. 实用肿瘤学杂志, 2020, 34(2): 133-138.
[9]	林玉华, 倪振华, 孙亦鹏, 毕俊杰, 王雄彪. SPDEF与恶性肿瘤关系的研究进展[J]. 实用肿瘤学杂志, 2020, 34(2): 185-188.
[10]	李亚飞, 张霄, 王雪飞, 翁明娇, 王天真. RNA结合蛋白Lin28在恶性肿瘤发生发展中的作用和分子机制[J]. 实用肿瘤学杂志, 2019, 33(5): 456-460.
[11]	常晓霞综述, 宋冰冰, 刘家仁审校. 植物化学物增加肿瘤细胞对化疗药物敏感性的研究进展[J]. 实用肿瘤学杂志, 2019, 33(1): 67-72.
[12]	阚钧, 周岱翰综述, 张恩欣审校. 肿瘤合并心血管疾病的研究进展[J]. 实用肿瘤学杂志, 2018, 32(6): 558-561.
[13]	王元综述, 孙轶华审校. β-连环蛋白在软组织肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2018, 32(5): 455-459.
[14]	范宁宁, 耿敬姝. 长链非编码RNA MEG3在人胶质瘤细胞中的表达及作用研究[J]. 实用肿瘤学杂志, 2018, 32(3): 219-223.
[15]	张永欣, 黄河. Galectin-9与多种恶性肿瘤的研究进展及作用机制探讨[J]. 实用肿瘤学杂志, 2018, 32(2): 159-163.

β-紫罗兰酮抗癌活性研究进展

Research progress in anticancer activity of β-ionone

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价